Custom Search

Register
Sign In
Sign In Using Facebook

AIDS Vaccine Research to Be Reassessed

February 07, 2008 at 11:21 AM AIDS/HIV News
  •   Print
  •   Share
  •   Comments
  •  Text 
AIDS Vaccine Research to Be Reassessed
After three AIDS vaccine trial failures, experts will gather in Maryland on March 25 to take stock of whatever has happened and decide on future strategies.


Last fall it was reported that some volunteers for a three-shot regimen by Merck might have left some volunteers more susceptible to HIV infection than before.

Scientists were badly shaken, and 15 vaccine researchers wrote to Dr. Tony Fauci, chief of the National Institute of Allergy and Infectious Diseases asking for a reassessment.

'When the STEP trial failed, it caused all of us to drop back a few yards,' said Fauci in a telephone interview.

Before the STEP two other trials had also collapsed, it may be noted here.

Also addressing the 15th annual Conference on Retroviruses and Opportunistic Infections in Boston, Ronald Desrosiers, director of the New England Regional Primate Research Center, said that the National Institutes of Health had 'lost its way,' and that current vaccine research trials were essentially futile.

'There is no rational basis for believing that any of the products in the pipeline have any reasonable hope of being effective,' said Desrosiers, a leading expert in vaccine studies using primates such as rhesus monkeys.

The only value of current or planned human vaccine trials, he noted sardonically, would be to prove that the products don't work.

'I would have used a different choice of words,' said Fauci, who does not believe his agency has 'lost its way.' However, he said, there was widespread consensus in the scientific community that more needed to be known about what biological steps were needed to cause the human immune system to ward off the virus.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  

guest

02/11/2008

this does not help me in my reasearch.




X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Immunology
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
AIDS
Complete Medindia Resources
News Categories:  
Senior Health Center

AIDS/HIV Related News

» AIDS Drug Venture in South Africa Worth $208 Million » Men Need More Attention in HIV Prevention
» Study Sheds Light on Psychiatric Symptoms and Functional Outcomes in HIV-Infected Youth » 20% Gay, Bisexual Men Unaware About Their HIV Positive Status
» Strained Global AIDS Fund Moves Focus Ten Years On » Scarce Access to Anti-Retrovirals for DR Congo HIV Patients
» Research Says Pet Love Helps Women Cope With HIV/AIDS » Saliva HIV Test as Accurate as Blood Test for HIV: Study
Read More >>